The Journal of allergy and clinical immunology
Audio Summaries

The SPRR2A-CSTA Axis Drives IL-17A-Induced Squamous Metaplasia and Steroid Resistance in Allergic Rhinitis

Jun 10, 2026

The authors investigate the molecular mechanisms driving squamous metaplasia (SM) and glucocorticoid resistance in refractory allergic rhinitis (AR), focusing on the role of the SPRR2A-CSTA axis. Their findings reveal that SPRR2A is a key marker associated with SM, promoting keratinization and steroid resistance through the action of CSTA. This study identifies the SPRR2A-CSTA axis as a potential therapeutic target and biomarker for managing refractory AR.

BCR ligation selectively inhibits IgE class switch recombination

Jun 10, 2026

The authors aimed to determine whether B cell receptor (BCR) signaling selectively inhibits IgE class switch recombination (CSR). Their findings indicate that stronger BCR signaling correlates with reduced frequencies of IgE-switched B cells in both mice and human B cell cultures, suggesting that BCR signaling uniquely suppresses IgE CSR through mechanisms involving specific signaling pathways and cytokine interactions. This research highlights the potential role of BCR signaling in regulating IgE production, which has implications for understanding allergic diseases.

Antigen-Specific mRNA-LNP Therapy with mTOR Inhibition Promotes Treg Cells and Limits Allergy

Jun 9, 2026

The authors investigate whether combining an allergen-encoded mRNA-lipid nanoparticle (mRNA-LNP) vaccine with an mTOR inhibitor can enhance regulatory T-cell responses and improve immune tolerance in allergic diseases. Their findings indicate that this combination effectively promotes the generation of regulatory T cells, reduces Th2 responses, and limits allergic symptoms in a preclinical model of asthma. This approach suggests a promising strategy for enhancing regulatory immunity in allergy treatment.